Nina Prokoph
8PUBLICATIONS
88CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 07, 2025
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.Raphael Lutz, Alexandra M Poos, Llorenç Solé-Boldo
|Apr 23, 2024
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.Perla Pucci, Liam C Lee, Miaojun Han
|Jun 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.Alexandra M Poos, Nina Prokoph, Moritz J Przybilla
|Jun 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.Cristina Mastini, Marco Campisi, Enrico Patrucco
|Oct 17, 2021
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.Elif Karaca Atabay, Carmen Mecca, Qi Wang
|Sep 23, 2021
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch
Pageof 2
Frequent Collaborators
5 joint publications
Suzanne D Turner
2 joint publications
Luca Mologni
2 joint publications
Huan-Chang Liang
2 joint publications
Falko Fend
2 joint publications
Carlo Gambacorti-Passerini
2 joint publications
Chiara Ambrogio
2 joint publications
Enrico Patrucco
2 joint publications
Ines Mota
2 joint publications
Olaf Merkel
2 joint publications
Lukas Kenner
